2 terminated, 1 completed, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow epitumomab: new trials by email Literature Review of epitumomab trials Research Report on epitumomab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer BTH1704, IMPRIME PGG, Gemcitabine - Pancreatic Cancer | Phase 1 | Terminated | University of Illinois at Chicago | 3 | 2014-08-01 | 2015-05-01 |
| Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer AS1402, Letrozole - Breast Carcinoma | Phase 2 | Terminated | Antisoma Research | 110 | 2008-09-01 | 2009-08-10 |
| Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer monoclonal antibody HuHMFG1 - Breast Cancer | Phase 1 | Completed | Jonsson Comprehensive Cancer Center | 24 | 2004-05-01 | 2013-06-26 |
| Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy monoclonal antibody HuHMFG1 - Breast Cancer | Phase 1 / Phase 2 | Unknown | Jonsson Comprehensive Cancer Center | 2003-05-01 | 2013-12-04 |
Breast Neoplasms (3) · Anophthalmia with pulmonary hypoplasia (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Jonsson Comprehensive Cancer Center (2) · Antisoma Research (1) · University of Illinois at Chicago (1)
United States (3) · Russia (1)
Mark D. Pegram, MD (2) · Gary Acton, MA MBBS MRCP (1) · Neeta Venepalli, MD (1) · Nuhad K Ibrahim, MD FACP (1)